Endocrine Society Urges Inclusion of Pregnant and Lactating Populations in Clinical Trials

June 20, 2024

Dear Chair Baldwin, Ranking Member Capito, Chair Aderholt, Ranking Member DeLauro, Chair Heinrich, Ranking Member Hoeven, Chair Harris, and Ranking Member Bishop,

"The 16 undersigned organizations of the Coalition to Advance Maternal Therapeutics (CAMT), a coalition of nonprofits, patients, providers, and industry groups committed to improving maternal health in the United States, urge you to prioritize maternal and infant health through the inclusion of pregnant and lactating populations in clinical trials within the Labor, Health and Human Services, Education and Related Agencies (LHHS) and the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (FDA-Ag) appropriations bills for fiscal year (FY) 2025."

arrow Read the Full Letter

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.